(Q34805259)

4 August 2017

1 reference

title

Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibody (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

Wendy S Putnam

1

1 reference

4 August 2017

Jing Li

2

1 reference

4 August 2017

Jonas Haggstrom

3

1 reference

4 August 2017

Chee Ng

4

1 reference

4 August 2017

Saloumeh Kadkhodayan-Fischer

5

1 reference

4 August 2017

Melissa Cheu

6

1 reference

4 August 2017

Yamo Deniz

7

1 reference

4 August 2017

Henry Lowman

8

1 reference

4 August 2017

Paul Fielder

9

1 reference

4 August 2017

Jennifer Visich

10

1 reference

4 August 2017

Amita Joshi

11

1 reference

4 August 2017

Nelson Shasha Jumbe

12

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

10

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

425-430

1 reference

The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Model-based drug development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Learning versus confirming in clinical drug development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

A Monte Carlo EM algorithm for generalized linear mixed models with flexible random effects distribution

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2751395

Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18686041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18686041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18686041

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1208/S12248-008-9045-4

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference